AMGN · Healthcare · $220.2B
After-hours $408.02+0.18%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 19 Drug Manufacturers - General peers
Quarterly Revenue Growth
“매출이 101억 달러로 전년 대비 10% 늘었고, 전분기 86억 달러에서 크게 반등했어요 — 리파타·이베니티·테제스파이어 등 6대 성장동력이 2”
In the company's words · 2026 2분기 earnings call